[1]
S. Elkolaly, D. Attele, and E. Ensrud, “A case of eculizumab-induced hemophagocytic lymphohistiocytosis (HLH) in a myasthenia gravis patient”, rrnmf, vol. 6, no. 2, Aug. 2025, doi: 10.17161/rrnmf.v6i2_2025.23412.